Ron Finklestien
Biotech Power Play – Windtree Therapeutics Strikes License Pact for Key Candidate
Biotech Power Play – Windtree Therapeutics Strikes License Pact for Key Candidate
Craig Fraser, CEO of Windtree Therapeutics, Inc. WINT, engaged in a recent interview with Benzinga. Windtree is pushing forward with late-stage interventions for cardiovascular ...
Jack Ma’s $50M Alibaba Buy Signals ‘Buy China’
Jack Ma’s Bold Move: $50 Million Alibaba Buy Signals ‘Buy China’
This week marked a resurgent rally in Chinese internet stocks, a welcome change following months of losses. The remarkable turn of events began with ...
Nunavut Greenlights White Cliff’s Copper Project
Nunavut Greenlights White Cliff’s Copper Project
After a decade-long consultation process culminating in September of last year, White Cliff has finally received approval to proceed with its copper project in ...
Stock Market Report: ZIM Integrated Shipping, iRobot, and More
Stock Market Report: ZIM Integrated Shipping, iRobot, and More
Justin Sullivan U.S. stock index futures on Monday largely hugged the flatline, as market participants geared up for a jam-packed week that will see ...
Eastman Chemical Company Poised for Q4 Earnings Announcement: An In-Depth Look
Eastman Chemical Company EMN is set to unveil its fourth-quarter 2023 results after the closing bell on Feb 1. In three of the last ...
NeuroSense’s (NASDAQ: NRSN) PrimeC Drug Offers Hope For ALS Patients Following Encouraging Phase 2b Trial
Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s Disease, is a devastating condition that gradually robs individuals of their ability to control muscle ...
SP500: Buckle Up For A 5-10% Correction
SP500: Buckle Up For A 5-10% Correction
Caution Advised The upcoming Federal Reserve meeting has the potential to trigger a significant 5-10% correction in the S&P 500 (SP500). Despite the potential ...
American Airlines Set for 32% Rally? Here’s What The Top Analysts Are Saying
American Airlines Set for 32% Rally? Here’s What The Top Analysts Are Saying
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, ...
Sarepta’s SRP-5051 Mid-Stage Trial Data Update
Positive Developments in Sarepta’s Phase 2 Trial of SRP-5051
Image Source: Hailshadow/iStock via Getty Images Sarepta Therapeutics (NASDAQ:SRPT) revealed a notable update on Monday, sharing additional results from its Phase 2 MOMENTUM study ...
Top 3 Oversold Industrial Stocks
Top 3 Industrial Stocks That May Surge in Value This Quarter
The industrials sector is ripe with opportunities, as oversold stocks present a chance to invest in undervalued companies. The RSI, a momentum indicator, reveals ...
